Nivolumab + Ipilimumab
Treatment used for 3 conditions
Total Trials
139
Total Participants
14K
Avg Effectiveness
84%
Avg Safety Score
33%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 3 conditions
Click on a condition to view detailed treatment information and clinical trial data.